Showing results (221-230 of 358) with videos related to

Sort By:
Pageof 36
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Economic Evaluation of Cinacalcet in the United States: The EVOLVE TrialVasily Belozeroff, Glenn M Chertow, Christopher N Graham, et al.
Current Medical Research and Opinion|September 11, 2007
Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonatesS R Earnshaw, C N Graham, B Ettinger, et al.
Journal of Immigrant and Minority Health|October 17, 2009
Leaving family for work: ambivalence and mental health among Mexican migrant farmworker menJoseph G Grzywacz, Sara A Quandt, Julie Early, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR StudySteven R Feldman, Yang Zhao, Isabelle Gilloteau, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 22, 2013
Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectivesSaagar Mahida, Andrew J Hogarth, Campbell Cowan, et al.
BJR Case Reports|September 14, 2020
<sup>18</sup>FDG-PET/CT findings in COVID-19: a single centre retrospective radiological reviewPia F P Charters, David Little, Jonathan C L Rodrigues, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2023
Distinct patterns of neurodegeneration after TBI and in Alzheimer's diseaseNeil S N Graham, James H Cole, Niall J Bourke, et al.
JAMA|May 1, 1996
Survival from early, intermediate, and late stages of HIV infectionC Enger, N Graham, Y Peng, et al.
The American Journal of Physiology|December 1, 1978
Heterogeneity of oxygen delivery in normoxic and hypoxic states: a fluorometer studyB Chance, C Barlow, Y Nakase, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2014
Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancerChristopher N Graham, Guy Hechmati, Jonas Hjelmgren, et al.
Pageof 36